Corrigendum to “The safety of extended dosing pembrolizumab when compared to traditional dosing: a review and meta-analysis of retrospective studies” [Lung Cancer 204 (2025) 108585]

Lung Cancer · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles